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Thrombosis of the hepatic artery (HAT) continues to be a serious complication following
orthotopic liver transplantation (OLTx). Several studies have failed to identify possible risk
factors that may be related to thrombosis of the hepatic artery. Nonetheless, a clear definition
of the responsible factors is necessary to formulate guidelines and protocols for the prevention
and management of this dreaded complication.
In the present study two homogeneous and comparable populations of pediatric patients
consisting of children who developed thrombosis of the hepatic artery after OLTx (HAT group)
and those who did not (control group) have been identified. An accurate statistical comparison
between these two groups has been carried out in an attempt to identify the responsible factors
leading to thrombosis and to develop a management protocol for this complication.
MATERIALS AND METHODS
Patient Population
During the calendar year 1986, 66 consecutive children under the age of 10 years underwent
an initial liver transplant at the Children’s Hospital of Pittsburgh. The methods of patient
selection, techniques for OLTx, protocols for immunosuppressive management and
postoperative care have been described in detail previously.1 A running continuous suture with
a “growth factor” was used for the arterial anastomoses. Some small-diameter vessels were
anastomosed using interrupted sutures.
The clinical management of all transplant recipients was comparable. Only hepatic artery
thrombosis (HAT) that occurred within 15 days of transplantation has been considered In the
HAT-group of patients. In these cases the diagnosis was clinically suspected in the presence
of fulminant hepatic necrosis, biliary leak, or recurrent bacteremia and was always confirmed
either by sonogram or angiography.
Cases in which a major complication occurred in the postoperative period were excluded from
the study. Thus, only patients with a relatively uneventful postoperative course during the first
month were included as a control group. The records of all these patients were reviewed.
Twenty-eight different perioperative variables from both the donor and the recipient were
recorded.
The anticoagulation therapy consisted of dextran 40, heparin, aspirin, or persantine and was
administered in a random fashion.
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Statistical Analysis
The variable listed in Tables 1 and 2 were investigated to determine whether there was any
statistically significant difference (p < 0.05) between “cases” (HAT group) and
“controls” (uneventful 15 days postoperative course).
Statistical analysis was performed at the Epidemiology Data Center of the University of
Pittsburgh, utilizing the BMDP statistical software package.
RESULTS
HAT occurred within 15 days after the transplant (mean = 53 ± 1.2 days) in 18 patients (26%
of the cases) and they were considered in this study as the hepatic artery thrombosis group.
Nineteen of the remaining 48 patients developed other major complications in the immediate
postoperative period (primary nonfunction, bleeding, sepsis, bowel perforation, biliary leak)
and thus were excluded. The control group consisted of 29 out of 48 patients (42%) in whom
the postoperative course was relatively uneventful. The two groups were comparable in terms
of age, sex, body weight, blood type predominance, and indication for OLTx.
Three surgically related factors were identified as being significantly associated with HAT
(Table 1), including (a) the diameter of the artery, determined intraoperatively, (b) the type of
arterial reconstruction, and (c) the number of times the anastomosis was redone to achieve a
satisfactory result.
The incidence of HAT was significantly higher (p < 0.05) in children who received an
intraoperative transfusion of fresh frozen plasma (FFP), compared to children who did not
receive FFP at all (Table 2). Other preoperative and intraoperative variables did not show any
significant differences between groups. The postoperative anticoagulant treatment was another
medical-related factor that was correlated significantly (p < 0.01) with the occurrence of HAT;
it was administered in almost 90% of the controls, which only 50% of the patients who
eventually developed thrombosis received it. A multivariate analysis of the variables that were
found to have a significant influence on the occurrence of HAT revealed that the
anticoagulation treatment was the only independent variable.
DISCUSSION
Hepatic artery thrombosis after transplantation, a devastating postoperative event associated
with significant morbidity and mortality, occurs in about 7 to 8% of the whole liver transplant
population.2–6 In the present study, 26% of children under 10 years of age who underwent an
initial liver transplant, developed thrombosis of the hepatic artery within 15 days. This HAT
group was compared to 29 patients (42% of the total series) who had a relatively uneventful
postoperative course.
Three “surgical” factors, consisting of the diameter of the hepatic artery (less than 3 mm), the
type of arterial anastomosis (end-to-end hepatic anastomosis versus other reconstructions, such
as use of iliac allograft or aortic conduit), and the number of times the arterial anastomosis had
to be redone to achieve a satisfactory intraoperative result, were all found to be statistically
different (p < 0.05), in comparing the HAT and the control groups. Similarly, two “medical”
factors, consisting of the intraoperative administration of FFP and postoperative anticoagulant
treatment with either heparin or dextran 40, were also found to be statistically different (p <
0.5) between groups.
This is the first report in which perioperative anticoagulant therapy has been identified as such
an important and statistically independent factor in the prevention of hepatic artery thrombosis
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after liver transplantation. The risk (odds ratio) of developing HAT in patients who did not
receive anticoagulant therapy was almost eight and five times greater than in patients who
received heparin and dextran, respectively.
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Table 1
“Surgical Factors” Analyzed for Possible Relationship with the Occurrence of Thrombosis of the Hepatic Artery
Variable Hepatic Artery Thrombosis Controls p value
Size of the hepatic artery (diameter) <3 mm 55.6% 24.1% <0.05
Level of the anastomosis Not significant
Anomalies in arterial anatomy Not significant
Kind of arterial reconstruction
 End-to-end 72.2% 93.1% <0.05
 Others 27.8% 6.8%
How many times the anastomosis was intraoperatively done
 One 66.7% 96.6% <0.02
 Two or more 33.3% 3.4%
Suture material Not significant
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